Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 126

Related Citations for PubMed (Select 22878614)

1.

Prognostication of vulvar cancer based on p14ARF status: molecular assessment of transcript and protein.

Lavorato-Rocha AM, de Melo Maia B, Rodrigues IS, Stiepcich MM, Baiocchi G, da Silva Cestari FM, Carvalho KC, Soares FA, Rocha RM.

Ann Surg Oncol. 2013 Jan;20(1):31-9. doi: 10.1245/s10434-012-2560-7. Epub 2012 Aug 10.

PMID:
22878614
2.

p14ARF, a prognostic predictor in HPV-negative vulvar carcinoma.

Knopp S, Nesland JM, Tropé C, Holm R.

Am J Clin Pathol. 2006 Aug;126(2):266-76.

3.

Does human papillomavirus infection imply a different prognosis in vulvar squamous cell carcinoma?

Alonso I, Fusté V, del Pino M, Castillo P, Torné A, Fusté P, Rios J, Pahisa J, Balasch J, Ordi J.

Gynecol Oncol. 2011 Sep;122(3):509-14. doi: 10.1016/j.ygyno.2011.05.016. Epub 2011 Jun 8.

PMID:
21652058
4.

Squamous cell carcinoma of the vulva: study of ploidy, HPV, p53, and pRb.

Lerma E, Matias-Guiu X, Lee SJ, Prat J.

Int J Gynecol Pathol. 1999 Jul;18(3):191-7.

PMID:
12090585
5.

Immunohistochemical analysis of p53 in vulval intraepithelial neoplasia and vulval squamous cell carcinoma.

Rosenthal AN, Hopster D, Ryan A, Jacobs IJ.

Br J Cancer. 2003 Jan 27;88(2):251-6.

6.

Prognostic significance of c-KIT in vulvar cancer: bringing this molecular marker from bench to bedside.

de Melo Maia B, Lavorato-Rocha AM, Rodrigues IS, Baiocchi G, Cestari FM, Stiepcich MM, Chinen LT, Carvalho KC, Soares FA, Rocha RM.

J Transl Med. 2012 Jul 28;10:150. doi: 10.1186/1479-5876-10-150.

7.

Role of TP53 mutations in vulvar carcinomas.

Choschzick M, Hantaredja W, Tennstedt P, Gieseking F, Wölber L, Simon R.

Int J Gynecol Pathol. 2011 Sep;30(5):497-504. doi: 10.1097/PGP.0b013e3182184c7a.

PMID:
21804386
8.

The pattern of p14ARF expression in primary and metastatic human endometrial carcinomas: correlation with clinicopathological features and TP53 pathway alterations.

Olcha P, Cybulski M, Skomra D, Obrzut B, Ignatov A, Jóźwik M, Schneider-Stock R, Semczuk A.

Int J Gynecol Cancer. 2010 Aug;20(6):993-9. doi: 10.1111/IGC.0b013e3181e76a4d.

PMID:
20683407
9.

Papillomavirus, p53 alteration, and primary carcinoma of the vulva.

Pilotti S, D'Amato L, Della Torre G, Donghi R, Longoni A, Giarola M, Sampietro G, De Palo G, Pierotti MA, Rilke F.

Diagn Mol Pathol. 1995 Dec;4(4):239-48.

PMID:
8634779
10.

Prognostic significance of lymph node variables and human papillomavirus DNA in invasive vulvar carcinoma.

Pinto AP, Schlecht NF, Pintos J, Kaiano J, Franco EL, Crum CP, Villa LL.

Gynecol Oncol. 2004 Mar;92(3):856-65.

PMID:
14984953
11.

Vulvar squamous cell carcinoma is a multifactorial disease following two separate and independent pathways.

van der Avoort IA, Shirango H, Hoevenaars BM, Grefte JM, de Hullu JA, de Wilde PC, Bulten J, Melchers WJ, Massuger LF.

Int J Gynecol Pathol. 2006 Jan;25(1):22-9.

PMID:
16306780
12.

A comparative analysis of human papillomavirus types 16 and 18 and expression of p53 gene and Ki-67 in cervical, vaginal, and vulvar carcinomas.

Koyamatsu Y, Yokoyama M, Nakao Y, Fukuda K, Saito T, Matsukuma K, Iwasaka T.

Gynecol Oncol. 2003 Sep;90(3):547-51.

PMID:
13678722
13.

microRNA portraits in human vulvar carcinoma.

de Melo Maia B, Lavorato-Rocha AM, Rodrigues LS, Coutinho-Camillo CM, Baiocchi G, Stiepcich MM, Puga R, de A Lima L, Soares FA, Rocha RM.

Cancer Prev Res (Phila). 2013 Nov;6(11):1231-41. doi: 10.1158/1940-6207.CAPR-13-0121. Epub 2013 Sep 18.

14.

Human papillomavirus (HPV) and HPV 16-variant distribution in vulvar squamous cell carcinoma in Sweden.

Larsson GL, Helenius G, Andersson S, Elgh F, Sorbe B, Karlsson MG.

Int J Gynecol Cancer. 2012 Oct;22(8):1413-9.

PMID:
23013732
15.

Presence of human papillomavirus (HPV) in vulvar squamous cell carcinoma (VSCC) and sentinel node.

Lindell G, Näsman A, Jonsson C, Ehrsson RJ, Jacobsson H, Danielsson KG, Dalianis T, Källström BN, Larson B.

Gynecol Oncol. 2010 May;117(2):312-6. doi: 10.1016/j.ygyno.2009.12.031. Epub 2010 Feb 6.

PMID:
20138657
16.

p16 overexpression identifies HPV-positive vulvar squamous cell carcinomas.

Santos M, Landolfi S, Olivella A, Lloveras B, Klaustermeier J, Suárez H, Alòs L, Puig-Tintoré LM, Campo E, Ordi J.

Am J Surg Pathol. 2006 Nov;30(11):1347-56.

PMID:
17063073
17.

Cytoplasmic expression of oestrogen receptor beta (ERβ) as a prognostic factor in vulvar squamous cell carcinoma in elderly women.

Zannoni GF, Prisco MG, Vellone VG, De Stefano I, Vizzielli G, Tortorella L, Fagotti A, Scambia G, Gallo D.

Histopathology. 2011 Nov;59(5):909-17. doi: 10.1111/j.1365-2559.2011.04029.x.

PMID:
22092402
18.
19.

TP53 and CDKN2a mutations in never-smoker oral tongue squamous cell carcinoma.

Heaton CM, Durr ML, Tetsu O, van Zante A, Wang SJ.

Laryngoscope. 2014 Jul;124(7):E267-73. doi: 10.1002/lary.24595. Epub 2014 Feb 20.

PMID:
24431303
20.

Promotor hypermethylation of p14ARF is a key alteration for progression of oral squamous cell carcinoma.

Ishida E, Nakamura M, Ikuta M, Shimada K, Matsuyoshi S, Kirita T, Konishi N.

Oral Oncol. 2005 Jul;41(6):614-22. Epub 2005 Apr 13.

PMID:
15975525
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk